(Allergan plc)

	AGN latest price $166.6054 (1.22%) ($163.3591 - $169.1379) on Wed. Feb. 7, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.66% (three month average)
RSI	41
Latest Price	$166.6054(1.22%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -1.1% a day on average for past five trading days.
Weekly Trend	AGN declines -4% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(47%)    ARKG(46%)    IVE(46%)
Factors Impacting AGN price	AGN will decline at least -0.83% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    UUP(-18%)    GDXJ(-5%)    SHY(-4%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.83% (StdDev 1.66%)
Hourly BBV	0 ()
Intraday Trend	0.9%

Resistance Level	$175.26
5 Day Moving Average	$167.16(-0.33%)
10 Day Moving Average	$173.66(-4.06%)
20 Day Moving Average	$175.26(-4.94%)
To recent high	-9.4%
To recent low	4.2%
Market Cap	$54.93b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed